Salvador Resino
Salvador Resino
Head of laboratory (Centro Nacional de Microbiología - Instituto de Salud Carlos III)
Dirección de correo verificada de - Página principal
TítuloCitado porAño
A combined score of pro-and anti-inflammatory interleukins improves mortality prediction in severe sepsis
D Andaluz-Ojeda, F Bobillo, V Iglesias, R Almansa, L Rico, F Gandía, ...
Cytokine 57 (3), 332-336, 2012
Host adaptive immunity deficiency in severe pandemic influenza
JF Bermejo-Martin, I Martin-Loeches, J Rello, A Antón, R Almansa, L Xu, ...
Critical Care 14 (5), R167, 2010
Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up
S Resino, R Resino, D Micheloud, D Gurbindo Gutiérrez, JA Léon, ...
Clin Infect Dis 42 (6), 862-9, 2006
Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C
MA Jiménez-Sousa, A Fernández-Rodríguez, M Guzmán-Fulgencio, ...
BMC medicine 11 (1), 6, 2013
Predictive Markers of Clinical Outcome in Vertically HIV-1–Infected Infants. A Prospective Longitudinal Study
S Resino, D Gurbindo, JM Bellón, S Sanchez-Ramón, ...
Pediatric research 47 (4), 509-515, 2000
Low Blood CD8^+ T-Lymphocytes and High Circulating Monocytes Are Predictors of HIV-1-Associated Progressive Encephalopathy in Children
S Sánchez-Ramón, JM Bellón, S Resino, C Cantó-Nogués, D Gurbindo, ...
PEDIATRICS-SPRINGFIELD- 111 (3), 421-421, 2003
Early natural killer cell counts in blood predict mortality in severe sepsis
D Andaluz-Ojeda, V Iglesias, F Bobillo, R Almansa, L Rico, F Gandía, ...
Critical Care 15 (5), R243, 2011
Modeling the probability of sustained virological response to therapy with pegylated interferon plus ribavirin in patients coinfected with hepatitis C virus and HIV
J Medrano, K Neukam, N Rallón, A Rivero, S Resino, S Naggie, A Caruz, ...
Clinical infectious diseases 51 (10), 1209-1216, 2010
Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: A meta‐analysis
M García‐Álvarez, D Pineda‐Tenor, MA Jiménez‐Sousa, ...
Hepatology 60 (5), 1541-1550, 2014
Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children
S Resino, R Resino, J Maria Bellón, D Micheloud, MD Gutiérrez, ...
Clin Infect Dis 43 (2), 243-52, 2006
CD38 Expression in CD8+ T Cells Predicts Virological Failure in HIV Type 1–Infected Children Receiving Antiretroviral Therapy
S Resino, JM Bellón, MD Gurbindo, MA Munoz-Fernández
Clinical infectious diseases 38 (3), 412-417, 2004
Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation
S Molina-Pinelo, A Vallejo, L Díaz, N Soriano-Sarabia, ...
Journal of Antimicrobial Chemotherapy 64 (3), 579-588, 2009
CD4+ T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy
S Resino, E Seoane, MDG Gutiérrez, JA León, MÁ Muñoz-Fernández
JAIDS Journal of Acquired Immune Deficiency Syndromes 42 (3), 269-276, 2006
Naïve and memory CD4+ T cells and T cell activation markers in HIV‐1 infected children on HAART
S Resino, J Navarro, JM Bellón, D Gurbindo, JA León, ...
Clinical & Experimental Immunology 125 (2), 266-273, 2001
Association between exposure to nevirapine and reduced liver fibrosis progression in patients with HIV and hepatitis C virus coinfection
J Berenguer, JM Bellón, P Miralles, E Álvarez, I Castillo, J Cosín, ...
Clinical infectious diseases 46 (1), 137-143, 2008
Extensive Implementation of Highly Active Antiretroviral Therapy Shows Great Effect on Survival and Surrogate Markers in Vertically HIV–Infected Children
S Resino, JM Bellón, R Resino, ML Navarro, JT Ramos, MI de José, ...
Clinical infectious diseases 38 (11), 1605-1612, 2004
Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients
IF de Castro, D Micheloud, J Berenguer, M Guzmán-Fulgencio, P Catalán, ...
AIDS 24 (13), 2059-2067, 2010
HIV‐infected children with moderate/severe immune‐suppression: changes in the immune system after highly active antiretroviral therapy
S Resino, I Galan, A Perez, JA Leon, E Seoane, D Gurbindo, ...
Clinical & Experimental Immunology 137 (3), 570-577, 2004
Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin
MA Jimenez-Sousa, R Almansa, C de la Fuente, A Caro-Paton, L Ruiz, ...
European Cytokine Network 21 (2), 84-91, 2010
Incidence of liver cirrhosis in HIV-infected patients with chronic hepatitis B or C in the era of highly active antiretroviral therapy
P Tuma, J Medrano, S Resino, E Vispo, A Madejón, C Sánchez-Piedra, ...
Antiviral therapy 15 (6), 881-6, 2010
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20